A carregar...
Retrospective Review of Atypical Femoral Fracture in Metastatic Bone Disease Patients Receiving Denosumab Therapy
BACKGROUND. Denosumab therapy is used to reduce skeletal‐related events in metastatic bone disease (MBD). There have been reports of atypical femoral fracture (AFF) in osteoporotic patients treated with denosumab but none in the context of higher dose and more frequent denosumab therapy for MBD. The...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5388375/ https://ncbi.nlm.nih.gov/pubmed/28275116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0192 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|